Kawasaki disease: Four case reports of cardiopathy with an institutional and literature review

Pediatric and Developmental Pathology

Volumn 10, Issue 6, 2007, Pages 491-499

  Ashrafi, Amir H ^a   Wang, Jenny ^a   Stockwell, Christina A ^a   Lloyd, David ^a   McAlvin, James B ^a   Russo, Pierre ^a   Shehata, Bahig M ^a,b  

^a Children's Healthcare of Atlanta ^*  (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intravenous immune globulin; Kawasaki disease; Vascular endothelial growth factor

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ADULT; ANEURYSM; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CHILD; FEMALE; FOLLOW UP; HEART ARREST; HEART DISEASE; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INFANT; MALE; MEDICAL LITERATURE; MOLECULAR GENETICS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SURVIVAL; THROMBOSIS; VASCULITIS;

ADULT; CHILD; FATAL OUTCOME; FEMALE; HEART DISEASES; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 37449006734     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-10-0172.1     Document Type: Review

References (57)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 1967;16:178.
2. Taubert KA, Rouwley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-282.
3. Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: a brief history. Pediatrics 200;106:E27.
4. Newbuger JW, Takahashi M, Taubert KA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2001;110:2747-2771.
5. Yanagawa H, Nakamura Y, Yashiro M, et al. I. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:E33.
6. Davis RL, Waller PL, Mueller BA, Dykewicz CA, Schonberger LB. Kawasaki syndrome in Washington State: race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med 1995;149:66-69.
7. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998;102:E65.
8. Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics 1989;84:666-669.
9. Harada F, Sada M, Kamiya T, Yanase Y, Kawasaki T, Sasazuki T. Genetic analysis of Kawasaki syndrome. Am J Hum Genet 1986;39:537-539.
10. Uehara R, Yahsiro M, Nakamura H, Yanagawa H. Kawasaki disease in parents and children. Acta Pediatr 2003;92:694-697.
11. Chang Ly, Chiang BL, Kao CL, et al. Lack of association between infection with novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis 2006;193:283-286.
12. Leung D, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting staphylococcus aureaus in Kawasaki syndrome. Lancet 1993;342:1385-1388.
13. Yoshioka T, Matsutani T, Toyosaki-Maeda T, et al. Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease. Pediatr Res 2003;53:403-410.
14. Nomura Y, Yoshinage M, Masuda K, et al. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age. Pediatr Infect Dis J 2003;22:794-798.
15. Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001;166:1334-1343.
16. Rowley AH, Baker SC, Shulman ST, et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis 2004;190:856-865.
17. Rowley A. The etiology of Kawasaki disease: a conventional infectious agent. Prog Pediatr Cardiol 2004;19:109-113.
18. Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings in 1,100 cases. Pediatr Cardiol 1986;7:3-9.
19. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-1385.
20. Noto N, Okada T, Yamasuge M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 2001;107:1095-1099.
21. Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol 2001;22:138-142.
22. Uziel Y, Hashkes PJ, Kassem E, Gottesman G, Wolach B. "Unresolving pneumonia" as the main manifestation of atypical Kawasaki disease. Arch Dis Child 2003;88:940-942.
23. Checchia PA, Borensztajn J, Shulman ST. Circulating cardiac troponin levels in Kawasaki disease. Pediatr Cardiol 2001;22:102-106.
24. Takahashi M. Myocarditis in Kawasaki syndrome: a minor villain? Circulation 1989;79:1398-1400.
25. Moran AM, Newburger JW, Sanders SP, et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J 200;139:217-223.
26. Gidding SS. Lare onset valvar dysfunction in Kawasaki disease. Prog Clin Biol Res 1987;250:305-309.
27. Hamamichi Y, Ichida F, Yu X, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res 2001;49:74-80.
28. Maeno N, Takei S, Masuda K, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998;44:596-599.
29. Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2000;159:424-429.
30. Terai M, Yasakawa K, Marumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999;83:337-339.
31. Yasakawa K, Terai M, Shulman ST, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002;105:766-769.
32. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992;153:557-562.
33. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-906.
34. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-2379.
35. Clauss M, Gerlach M, Herlach H, et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-1545.
36. Melder RJ, Koening GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cells adhesion and tumor endothelium. Nat Med 1996;2:992-997.
37. Jeanette JC, Sciarrorota J, Takahashi K, Naoe S. Predominance of monocytes and macrophages in the inflammatory infiltrates of acute Kawasaki disease arteritis. Pediatr Res 2002;53:94A.
38. Rowley AH, Eckerley AC, Jack HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997;159:5946-5955.
39. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-544.
40. Fukazawa R, Sonobe T, Hamamoto K, et al. Possible synergic effects of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-I receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 2004;56:597-601.
41. Wu SF, Chang JS, Peng CT, et al. Polymorphism of angiotensin-I converting enzyme gene and Kawasaki disease. Pediatr Cardiol 2004;25:529-533.
42. Kuniyuki S, Asada M. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. J Am Acad Dermatol 1997;37:303-304.
43. McMorrow Tuohy AM, Tani LY, Cetta F, et al. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol 2001;88:328-330.
44. Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocardiography in children with Kawasaki disease. Pediatrics 199;104:E57.
45. Furuno K, Yuge T, Kusuhara K, et al. CD25+CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 2004;145:385-390.
46. Yeung R. Pathogenesis and treatment of Kawasaki disease. Curr Opin Rheumatol 2005;17:617-623.
47. Ahn SY, Jang GC, Shin JS, et al. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonesei Med J 2003;44:1021-1026.
48. Quasney MW, Bronstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease. Pediatr Res 2001;49:686-690.
49. Chien YH, Chang KW, Yang YH, et al. Association between levels of TNF-alpha and TNF-alpha promoter-308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc 2003;102:174-150.
50. Shintaro K, Akira Y, Takafumi H, Hirohisa K, Kyogo I. Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with history of Kawasaki disease. Pediatr Int 1999;41:341-345.
51. Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS. Infliximab as novel therapy for refractory Kawasaki disease. J Rheumatol 2004;31:808-810.
52. Nishimura A, Zaitsu M, Hara M, et al. A polymorphism in the promoter of the CD 14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 2003;143:357-362.
53. Biezeveld MH, Kulpers IM, Geissler J, et al. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet 2003;361:1268-1270.
54. Cheung YF, No MH, Ip WK, et al. Modulating effects of mannose-binding lectin genotype on arterial stiffness in children after Kawasaki disease. Pediatr Res 2004;56:591-596.
55. Ye F, Foell D, Hirono KL, et al. Neutrophil-derived S100A12 is profoundly unregulated in the early stage of acute Kawasaki disease. Am J Cardiol 2004;94:840-844.
56. Shikishima Y, Saeki T, Matsuura N. Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10. Asian Pac J Allergy Immunol 2003;21:139-143.
57. Miura M, Garcia FL, Crawford SE, Rowley AH. Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease. Pediatr Infect Dis J 2004;23:931-936